Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [Phase 2]
This Phase 2 trial of talampanel in recurrent high-grade gliomas was terminated. No results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial evaluating imatinib mesylate plus hydroxyurea for recurrent glioblastoma multiforme was terminated; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme [Phase 3]
Phase 3 trial comparing standard radiation therapy, higher-dose radiation therapy, or chemotherapy for older patients with glioblastoma mult…
-
CLINICAL_TRIALS research · 2011-04-12Clinical Trial Update: Establishment of a Brain and Spinal Tumor Tissue Bank
Clinical trial update describing the establishment of a brain and spinal tumor tissue bank sponsored by Taipei Medical University WanFang Ho…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Vitamin D for Treatment of Glioblastoma Multiforme [Phase 1, Phase 2]
This update reports on a Phase 1/Phase 2 trial evaluating Vitamin D for glioblastoma multiforme, with the trial status currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2010-12-16Clinical Trial Update: Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating amino-acid PET-guided re-irradiation versus MRI-guided re-irradiation in patients with recurrent glioblast…
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme [Phase 1]
This is a Phase 1 clinical trial update evaluating CT-322 in combination with radiation therapy and temozolomide for newly diagnosed gliobla…
-
CLINICAL_TRIALS research · 2010-10-27Clinical Trial Update: CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan [Phase 2]
Phase 2 clinical trial update evaluating CT-322 with irinotecan for recurrent glioblastoma multiforme; sponsored by Adnexus (a Bristol-Myers…
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme [Phase 1, Phase 2]
Phase I/II trial evaluating temozolomide with ZARNESTRA (R115777) in recurrent and progressive glioblastoma multiforme completed with result…
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: SUTENT (SUNITINIB, SU11248)in Patients With Recurrent or Progressive Glioblastoma Multiforme [Phase 2]
A Phase 2 trial of Sutent (sunitinib) in patients with recurrent or progressive glioblastoma multiforme is being reported. The current statu…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 study of temsirolimus in combination with bevacizumab for recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS withdrawal · 2010-01-12Clinical Trial Update: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors [Phase 2]
Phase 2 trial of photodynamic therapy for malignant intracranial tumors has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2009-12-30Clinical Trial Update: Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme [Phase 2]
This Phase 2 trial evaluating TLN-4601 in patients with recurring glioblastoma multiforme was terminated.
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Radiation Boost for Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating a radiation boost for newly diagnosed glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma [Phase 2]
This document provides an update on a Phase 2 clinical trial of 131-I-TM-601 in adults with recurrent high-grade glioma, sponsored by TransM…
-
CLINICAL_TRIALS withdrawal · 2009-01-07Clinical Trial Update: Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme [Phase 3]
Phase 3 trial of TransMID™ for glioblastoma multiforme has been withdrawn.
-
FDA approval · 2006-10-19FDA Approved: TEMODAR — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA has approved a supplemental application for Temodar (temozolomide) submitted by Merck Sharp & Dohme LLC. The notice indicates a regu…
-
CLINICAL_TRIALS research · 2006-09-08Clinical Trial Update: Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) [Phase 1, Phase 2]
A phase 1/2 safety study evaluating cetuximab with radiotherapy and temozolomide for glioblastoma multiforme; the current status is unknown.